Advertising, eMarketing and Promotions for the Pharmaceutical Industry 2011

Pharmaceutical Online Ad Spending is Expected to Hit $1 Billion in 2010 and Keep Rising Through 2014

U.S. health-care and pharmaceutical online advertising spending will reach $1 billion for the first time this year, up 10.6% from last year, according eMarketer. By 2014, online ad spending in the health-care and pharmaceutical industry, which includes direct-to-consumer and over-the-counter remedies, is expected to reach $1.52 billion. Ensure your digital strategy is keeping up with the latest advertising trends.

As the industry anxiously awaits the FDA s Social Media Guidelines, the presence of potentially uncontrollable content has caused pharmaceutical companies to be fearful of social media, and correspondingly slow to get involved. American Conference Institute s 9th Expert Regulatory Guide to Advertising, eMarketing, and Promotions for the Pharmaceutical Industry will provide the guidance desperately needed by the pharmaceutical manufacturers in order to maximize the use of the internet and social media.

Key Federal and State Regulators Will Share Insights for Avoiding Government Scrutiny

The FDA is issuing warning letters at its fastest rate ever. Ensure you are ready to respond. This program will give you the unique opportunity to hear from regulators at the forefront of pharmaceutical advertising and promotion and enforcement. Speakers such as DDMAC; Lesley Fair, Federal Trade Commission; Gene Fishel, Virginia Attorney General s Office; Douglas Gansler, Maryland Attorney General s Office; Margaret Hutchinson, U.S. Department of Justice; and John Krayniak, New Jersey Medicare Fraud Unit, will tell you their upcoming enforcement priorities.

Maintain Control in Order to Mount a Successful Promotional Program.

ACI s conference will provide the leading forum for manufacturers to develop compliant advertising and promotional programs without running afoul of FDA guidelines. With so many areas for potential pitfalls, it is important to learn how to create a compliant digital strategy and social media policy and ensure that your direct-to-consumer advertisements are presented in a clear, conspicuous, and neutral manner. Additionally, in-house experts will directly address how to ensure that you are using the best available practices to safely present your product information via advertising and promotions.

Post-Conference Workshops Give You the Opportunity to Gain Valuable, Real-World Experience

ACI has added two post-conference workshops to enhance your conference experience. By attending these interactive sessions, you have the opportunity to go in-depth with industry leaders. In Workshop A, learn how to Utilize Social Media in FDA-Regulated Industries. Workshop B will teach you how to conduct a Hands-On Pharmaceutical Advertising Review.